These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20105045)

  • 1. Timing of bolus in children with type 1 diabetes using continuous subcutaneous insulin infusion (TiBoDi Study).
    Scaramuzza AE; Iafusco D; Santoro L; Bosetti A; De Palma A; Spiri D; Mameli C; Zuccotti GV
    Diabetes Technol Ther; 2010 Feb; 12(2):149-52. PubMed ID: 20105045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lowering postprandial glycemia in children with type 1 diabetes after Italian pizza "margherita" (TyBoDi2 Study).
    De Palma A; Giani E; Iafusco D; Bosetti A; Macedoni M; Gazzarri A; Spiri D; Scaramuzza AE; Zuccotti GV
    Diabetes Technol Ther; 2011 Apr; 13(4):483-7. PubMed ID: 21355715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Timing of meal insulin boluses to achieve optimal postprandial glycemic control in patients with type 1 diabetes.
    Cobry E; McFann K; Messer L; Gage V; VanderWel B; Horton L; Chase HP
    Diabetes Technol Ther; 2010 Mar; 12(3):173-7. PubMed ID: 20151766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
    Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
    Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between preprandial vs. postprandial insulin aspart in patients with type 1 diabetes on insulin pump and real-time continuous glucose monitoring.
    Thuillier P; Sonnet E; Alavi Z; Roudaut N; Nowak E; Dion A; Kerlan V
    Diabetes Metab Res Rev; 2018 Sep; 34(6):e3019. PubMed ID: 29749032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy comparison between preprandial and postprandial insulin aspart administration with dose adjustment for unpredictable meal size.
    Jovanovic L; Giammattei J; Acquistapace M; Bornstein K; Sommermann E; Pettitt DJ
    Clin Ther; 2004 Sep; 26(9):1492-7. PubMed ID: 15531011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The additional dose of insulin for high-protein mixed meal provides better glycemic control in children with type 1 diabetes on insulin pumps: randomized cross-over study.
    Piechowiak K; Dżygało K; Szypowska A
    Pediatr Diabetes; 2017 Dec; 18(8):861-868. PubMed ID: 28117542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dual-wave bolus feature in continuous subcutaneous insulin infusion pumps controls prolonged post-prandial hyperglycaemia better than standard bolus in Type 1 diabetes.
    Lee SW; Cao M; Sajid S; Hayes M; Choi L; Rother C; de León R
    Diabetes Nutr Metab; 2004 Aug; 17(4):211-6. PubMed ID: 15575341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing the combination insulin bolus split for a high-fat, high-protein meal in children and adolescents using insulin pump therapy.
    Lopez PE; Smart CE; McElduff P; Foskett DC; Price DA; Paterson MA; King BR
    Diabet Med; 2017 Oct; 34(10):1380-1384. PubMed ID: 28574182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Better postprandial glucose stability during continuous subcutaneous infusion with insulin aspart compared with insulin lispro in patients with type 1 diabetes.
    Bartolo PD; Pellicano F; Scaramuzza A; Sardu C; Casetti T; Bosi E; Miselli V; Brandolini S; Fabbri T; Meandri P; Cannatà F
    Diabetes Technol Ther; 2008 Dec; 10(6):495-8. PubMed ID: 19049379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing postprandial glycemia in pediatric patients with type 1 diabetes using insulin pump therapy: impact of glycemic index and prandial bolus type.
    O'Connell MA; Gilbertson HR; Donath SM; Cameron FJ
    Diabetes Care; 2008 Aug; 31(8):1491-5. PubMed ID: 18509207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automated overnight closed-loop glucose control in young children with type 1 diabetes.
    Elleri D; Allen JM; Nodale M; Wilinska ME; Mangat JS; Larsen AM; Acerini CL; Dunger DB; Hovorka R
    Diabetes Technol Ther; 2011 Apr; 13(4):419-24. PubMed ID: 21355719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre- and postprandial hyperinsulinemia during insulin pump treatment; role of the subcutaneous bolus and basal infusion.
    Olsson PO; Jorfeldt L; Arnqvist H; Gerhardsson P
    Diabetes Res; 1991 Feb; 16(2):55-61. PubMed ID: 1817806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the post-meal glucose response to different insulin bolus waveforms in insulin pump- and pre-meal pramlintide-treated type 1 diabetes patients.
    King AB
    Diabetes Technol Ther; 2010 Feb; 12(2):105-8. PubMed ID: 20105039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal insulin pump dosing and postprandial glycemia following a pizza meal using the continuous glucose monitoring system.
    Jones SM; Quarry JL; Caldwell-McMillan M; Mauger DT; Gabbay RA
    Diabetes Technol Ther; 2005 Apr; 7(2):233-40. PubMed ID: 15857224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefit of supplementary fat plus protein counting as compared with conventional carbohydrate counting for insulin bolus calculation in children with pump therapy.
    Kordonouri O; Hartmann R; Remus K; Bläsig S; Sadeghian E; Danne T
    Pediatr Diabetes; 2012 Nov; 13(7):540-4. PubMed ID: 22765260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter closed-loop/hybrid meal bolus insulin delivery with type 1 diabetes.
    Chase HP; Doyle FJ; Zisser H; Renard E; Nimri R; Cobelli C; Buckingham BA; Maahs DM; Anderson S; Magni L; Lum J; Calhoun P; Kollman C; Beck RW;
    Diabetes Technol Ther; 2014 Oct; 16(10):623-32. PubMed ID: 25188375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefits of a bolus calculator in pre- and postprandial glycaemic control and meal flexibility of paediatric patients using continuous subcutaneous insulin infusion (CSII).
    Shashaj B; Busetto E; Sulli N
    Diabet Med; 2008 Sep; 25(9):1036-42. PubMed ID: 18937673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
    Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M
    Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of optimal insulin administration timing for standard carbohydrates-rich meals using continuous glucose monitoring in children with type 1 diabetes: A cross-over randomized study.
    Tucholski K; Sokołowska M; Tucholska D; Kamińska H; Jarosz-Chobot P
    J Diabetes Investig; 2019 Sep; 10(5):1237-1245. PubMed ID: 30768859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.